Tenon Medical Raises $4.3 Million in Private Placement
Tenon Medical (TNON) recently completed a private placement, raising $4.3 million through senior convertible promissory notes. These notes, maturing in September 2026, are convertible into common stock at a discount to recent trading prices. The company plans to use the proceeds for commercial expansion, product development, clinical studies, and general corporate purposes, aiming to strengthen its growth in the SI joint device market.
MAR 12·Weatherford Democrat▲
Tenon Medical Announces Closing of Private Placement of Senior Convertible Notes Offering for Gross Proceeds of $ 4.3 Million
Tenon Medical, Inc. has successfully closed a private placement of senior convertible promissory notes, raising an aggregate gross proceeds of $4.3 million. The funds are earmarked for commercial expansion, product development, clinical studies, working capital, and general corporate purposes. The notes are convertible into shares of the Company's common stock at a conversion price equal to 80% of the VWAP for the three trading days immediately prior to the conversion date.
MAR 12·Stock Titan▲
Tenon Medical raises $4.3M to expand sacro-pelvic disorder care
Tenon Medical (NASDAQ: TNON) has closed a private placement of senior convertible notes, raising $4.3 million in gross proceeds. The funds are earmarked for commercial expansion, product development, clinical studies, and general corporate purposes, aiming to advance care for sacro-pelvic disorders. The notes have a 20% original issue discount and mature in September 2026, with conversion possible after six months at 80% of the 3-day VWAP.
